ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an Update

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00399347
Recruitment Status : Unknown
Verified November 2006 by HaEmek Medical Center, Israel.
Recruitment status was:  Active, not recruiting
First Posted : November 14, 2006
Last Update Posted : November 14, 2006
Sponsor:
Information provided by:
HaEmek Medical Center, Israel

Brief Summary:
The prevalence and incidence of diabetes has been reported to vary among populations.Immigrants groups as that have undergone significant life-style changes tend to develop diabetes within a short time. The aim of the study is to assess the prevalence of diabetes mellitus in Ethiopian population ,15-20 years after immigration in Israel.

Condition or disease
Diabetes Mellitus

Detailed Description:
The study will be conducted in three primary care clinics of the Jezreel Valley (Omer, Givat Hamore and Afula Illit). The computerized medical charts of 500 Ethiopian adults will be reviewed. The following information will be obtained: age, date of arrival in Israel, known history of diabetes, hyperlipidemia, hypertension or other disease, drug therapy, body weight, blood pressure. Following laboratory data will be retrieved: blood glucose, HbA1c, lipid levels , creatinine and uric acid. The criteria used for the definition of diabetes will be based on the criteria proposed by the American Diabetes Association .

Study Type : Observational
Enrollment : 500 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Prevalence of Diabetes Mellitus in Ethiopian Community in Israel: an Update
Study Start Date : January 2005
Study Completion Date : December 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   33 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female Ethiopians Jews who immigrate in Israel in 1991 and were 18 years old or more at immigration.

Exclusion Criteria:

  • Type 1 diabetes Mellitus

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00399347


Locations
Israel
Primary care clinics
Afula, Israel
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Avraham Ishay MD HaEmek Medical Center, Afula, Israel

ClinicalTrials.gov Identifier: NCT00399347     History of Changes
Other Study ID Numbers: 4940706
First Posted: November 14, 2006    Key Record Dates
Last Update Posted: November 14, 2006
Last Verified: November 2006

Keywords provided by HaEmek Medical Center, Israel:
Diabetes Mellitus, prevalence , Ethiopians Jews, Israel

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases